{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:53:47Z","timestamp":1783745627730,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1053\/j.jvca.2021.11.005","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T22:47:24Z","timestamp":1637880444000},"page":"1343-1349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Inhaled Pulmonary Vasodilator Utilization and Cost Following Initiation of a Protocol in a Quaternary Academic Heart Center Intensive Care Unit"],"prefix":"10.1053","volume":"36","author":[{"given":"Daniel R.","family":"Austin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth T.","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2021.11.005_bib0001","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.125.2.580","article-title":"Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension","volume":"125","author":"Leuchte","year":"2004","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2021.11.005_bib0002","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric Pulmonary hypertension: Guidelines from the American Heart Association and","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.11.005_bib0003","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1213\/ANE.0000000000002138","article-title":"Aerosolized vasodilators for the treatment of pulmonary hypertension in cardiac surgical patients: A systematic review and meta-analysis","volume":"125","author":"Elmi-Sarabi","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.11.005_bib0004","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.jvca.2017.12.014","article-title":"Inhaled nitric oxide (iNO) and inhaled epoprostenol (iPGI2) use in cardiothoracic surgical patients: Is there sufficient evidence for evidence-based recommendations?","volume":"32","author":"Rao","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.11.005_bib0005","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.jvca.2005.03.036","article-title":"Pro: Inhaled prostaglandin as a pulmonary vasodilator instead of nitric oxide","volume":"19","author":"Augoustides","year":"2005","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.11.005_bib0006","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.jvca.2005.03.037","article-title":"Inhaled prostaglandin as a pulmonary vasodilator instead of nitric oxide","volume":"19","author":"Con","year":"2005","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.11.005_bib0007","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1067\/mtc.2003.107","article-title":"Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery","volume":"125","author":"Hach\u00e9","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2021.11.005_bib0008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2459\/01.JCM.0000203850.97890.fe","article-title":"Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: A randomized, prospective, double-blind study","volume":"7","author":"Fattouch","year":"2006","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1053\/j.jvca.2021.11.005_bib0009","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jtcvs.2009.04.063","article-title":"A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients","volume":"138","author":"Khan","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2021.11.005_bib0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1060028015608865","article-title":"A comparison of inhaled nitric oxide versus inhaled epoprostenol for acute pulmonary hypertension following cardiac surgery","volume":"50","author":"McGinn","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.jvca.2021.11.005_bib0011","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11748-016-0724-2","article-title":"A prospective, randomized study of inhaled prostacyclin versus nitric oxide in patients with residual pulmonary hypertension after pulmonary endarterectomy","volume":"65","author":"Abe","year":"2017","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2021.11.005_bib0012","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.jvca.2007.10.015","article-title":"Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: A prospective randomized trial","volume":"22","author":"Winterhalter","year":"2008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.11.005_bib0013","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF01705726","article-title":"Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide","volume":"20","author":"Young","year":"1994","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2021.11.005_bib0014","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/AOG.0000000000004128","article-title":"High concentrations of nitric oxide inhalation therapy in pregnant patients with severe coronavirus disease 2019 (COVID-19)","volume":"136","author":"Safaee Fakhr","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.jvca.2021.11.005_bib0015","first-page":"487","article-title":"Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro","volume":"14","author":"Saniabadi","year":"1984","journal-title":"Haemostasis"},{"key":"10.1053\/j.jvca.2021.11.005_bib0016","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.4187\/respcare.05344","article-title":"The effect of nebulizer position on aerosolized epoprostenol delivery in an adult lung model","volume":"62","author":"Anderson","year":"2017","journal-title":"Respir Care"},{"key":"10.1053\/j.jvca.2021.11.005_bib0017","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/ALN.0000000000001611","article-title":"Clinical complications with the delivery of inhaled epoprostenol in the operating room","volume":"127","author":"Bhatt","year":"2017","journal-title":"Anesthesiology"},{"issue":"64","key":"10.1053\/j.jvca.2021.11.005_bib0018","first-page":"1567","article-title":"Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma","volume":"1988","author":"Hardy","year":"1985","journal-title":"J Appl Physiol"},{"key":"10.1053\/j.jvca.2021.11.005_bib0019","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/0310057X0002800206","article-title":"Pulmonary toxicity of inhaled aerosolized prostacyclin therapy\u2013an observational study","volume":"28","author":"van Heerden","year":"2000","journal-title":"Anaesth Intensive Care"},{"key":"10.1053\/j.jvca.2021.11.005_bib0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/1091581820945985","article-title":"Novel toxicology program to support the development of inhaled VentaProst","volume":"39","author":"Tepper","year":"2020","journal-title":"Int J Toxicol"},{"key":"10.1053\/j.jvca.2021.11.005_bib0021","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1213\/XAA.0000000000000886","article-title":"Noninvasive administration of inhaled epoprostenol and inhaled milrinone in extubated, spontaneously breathing patients with right ventricular failure and portal hypertension: A report of 2 cases","volume":"12","author":"Couture","year":"2019","journal-title":"A A Pract"},{"key":"10.1053\/j.jvca.2021.11.005_bib0022","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/jamp.2015.1219","article-title":"Aerosol therapy in adults receiving high flow nasal cannula oxygen therapy","volume":"29","author":"R\u00e9miniac","year":"2016","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1053\/j.jvca.2021.11.005_bib0023","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.4187\/respcare.05127","article-title":"Aerosol delivery through adult high flow nasal cannula with Heliox and oxygen","volume":"62","author":"Dailey","year":"2017","journal-title":"Respir Care"},{"key":"10.1053\/j.jvca.2021.11.005_bib0024","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.3390\/pharmaceutics11050225","article-title":"The ratio of nasal cannula gas flow to patient inspiratory flow on trans-nasal pulmonary aerosol delivery for adults: An in vitro study","volume":"11","author":"Li","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1053\/j.jvca.2021.11.005_bib0025","doi-asserted-by":"crossref","first-page":"590","DOI":"10.21037\/atm-20-7383","article-title":"Narrative review of practical aspects of aerosol delivery via high-flow nasal cannula","volume":"9","author":"Li","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1053\/j.jvca.2021.11.005_bib0026","doi-asserted-by":"crossref","first-page":"E464","DOI":"10.3390\/jcm9020464","article-title":"The clinical impact of flow titration on epoprostenol delivery via high flow nasal cannula for ICU patients with pulmonary hypertension or right ventricular dysfunction: A retrospective cohort comparison study","volume":"9","author":"Li","year":"2020","journal-title":"J Clin Med"},{"key":"10.1053\/j.jvca.2021.11.005_bib0027","first-page":"391","article-title":"Off-label use reimbursement","volume":"64","author":"Cohen","year":"2009","journal-title":"Food Drug Law J"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021009708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021009708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:58:24Z","timestamp":1760947104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077021009708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1053077021009708"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2021.11.005","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled Pulmonary Vasodilator Utilization and Cost Following Initiation of a Protocol in a Quaternary Academic Heart Center Intensive Care Unit","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2021.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}